Tags:AnalyticsLearnMedicalMedTechSoftware
Elucid Vivo provides clinical solutions based on histology & machine learning. We provide solutions for lipid rich necrotic core, atherosclerotic plaque, CTA plaque analysis, risk of heart attack, and stroke.
Total raised: $27M

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
23.06.2022Series B$27M-finsmes.co...

Mentions in press and media 2

DateTitleDescriptionCategoryAuthorSource
24.06.2022Elucid cle...No, it’s not a dream—Boston-ba...MedTech-fiercebiot...
23.06.2022Elucid Rai...Elucid, a Boston, MA-company d...USA-finsmes.co...